Unfortunately the procedural side of the approval process isn't my area of expertise - just noting the use case is absolutely there for Leronlimab to be applied to the pediatric inflammation (Kawasaki) like cases that are unfortunately being reported. Sorry I can't be more helpful on the procedural side!